HUP0300798A2 - Szubsztituált triazolopirimidin-származékok és alkalmazásuk rákellenes hatóanyagként és ezeket tartalmazó gyógyszerkészítmények - Google Patents
Szubsztituált triazolopirimidin-származékok és alkalmazásuk rákellenes hatóanyagként és ezeket tartalmazó gyógyszerkészítményekInfo
- Publication number
- HUP0300798A2 HUP0300798A2 HU0300798A HUP0300798A HUP0300798A2 HU P0300798 A2 HUP0300798 A2 HU P0300798A2 HU 0300798 A HU0300798 A HU 0300798A HU P0300798 A HUP0300798 A HU P0300798A HU P0300798 A2 HUP0300798 A2 HU P0300798A2
- Authority
- HU
- Hungary
- Prior art keywords
- group
- optionally substituted
- carbon atom
- carbon
- atom
- Prior art date
Links
- -1 Substituted-triazolopyrimidines Chemical class 0.000 title 1
- 239000002246 antineoplastic agent Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 229910052799 carbon Inorganic materials 0.000 abstract 18
- 150000001721 carbon Chemical group 0.000 abstract 14
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 4
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 4
- 125000005843 halogen group Chemical group 0.000 abstract 4
- 125000000623 heterocyclic group Chemical group 0.000 abstract 4
- 241000124008 Mammalia Species 0.000 abstract 3
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 3
- 125000003277 amino group Chemical group 0.000 abstract 3
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 3
- 125000004400 (C1-C12) alkyl group Chemical group 0.000 abstract 2
- 206010048723 Multiple-drug resistance Diseases 0.000 abstract 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 125000003282 alkyl amino group Chemical group 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000004414 alkyl thio group Chemical group 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 125000004104 aryloxy group Chemical group 0.000 abstract 2
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 abstract 2
- 125000004663 dialkyl amino group Chemical group 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 210000004881 tumor cell Anatomy 0.000 abstract 2
- 125000004642 (C1-C12) alkoxy group Chemical group 0.000 abstract 1
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 150000001602 bicycloalkyls Chemical group 0.000 abstract 1
- 230000005907 cancer growth Effects 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 125000004438 haloalkoxy group Chemical group 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 125000001544 thienyl group Chemical group 0.000 abstract 1
- YWBFPKPWMSWWEA-UHFFFAOYSA-O triazolopyrimidine Chemical class BrC1=CC=CC(C=2N=C3N=CN[N+]3=C(NCC=3C=CN=CC=3)C=2)=C1 YWBFPKPWMSWWEA-UHFFFAOYSA-O 0.000 abstract 1
- 230000004614 tumor growth Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
A találmány (I) általános képletű szubsztituált triazolopirimidin-származékok alkalmazására vonatkozik, amelyek rákos tumorsejteknövekedésének gátlására és a tumorsejtek növekedésével kapcsolatosbetegségek kezelésére használhatók emlősöknél, a kezelés során akezelésre szoruló emlősnek a vegyületek vagy farmakológiailagelfogadható sóik hatékony mennyiségét adagolják. A találmány továbbá avegyületek emlősök esetén többszörös hatóanyag-rezisztencia(MDR=multiple drug resistance) kezelésében vagy megelőzésében valóalkalmazására is vonatkozik. Szubsztituált triazoloprimidin-származékként valamely (I) általános képletű vegyületet vagyfarmakológiailag elfogadható sóját alkalmazzuk, a képletben R1jelentése halogénatom, adott esetben szubsztituált 1-12 szénatomosalkilcsoport, adott esetben szubsztituált 2-12 szénatomosalkenilcsoport, adott esetben szubsztituált 2-12 szénatomosalkinilcsoport, adott esetben szubsztituált 4-12 szénatomosalkadienilcsoport, 1-12 szénatomos alkoxicsoport, adott esetbenszubsztituált 6, 10 vagy 14 szénatomos arilcsoport, cianocsoport,hidroxilcsoport, halogénatom, karbamoilcsoport, karboxilcsoport, 2-12szénatomos alkoxikarbonilcsoport, heterociklusos csoport, adottesetben szubsztituált 5-10 szénatomos bicikloalkilcsoport, adottesetben szubsztituált 3-8 szénatomos cikloalkilcsoport; R2 jelentésehidrogénatom, adott esetben szubsztituált 1-12 szénatomosalkilcsoport, aminocsoport, hidroxilcsoport, 1-12 szénatomosalkiltiocsoport, cianocsoport, karbamoilcsoport, adott esetbenszubsztituált 1-12 szénatomos alkoxicsoport, adott esetbenszubsztituált 3-8 szénatomos cikloalkilcsoport, adott esetbenszubsztituált 6, 10 vagy 14 szénatomos arilcsoport, karboxilcsoport,2-12 szénatomos alkoxikarbonilcsoport, ariloxicsoport,benziloxicsoport, tienilcsoport, heterociklusos csoport R3 jelentésehidrogénatom, halogénatom, 1-12 szénatomos alkilcsoport, 1-12szénatomos alkoxicsoport, ariloxicsoport, NRcRd általános képletűcsoport, benziloxicsoport, aralkoxicsoport, 1-12 szénatomoshalogénalkoxicsoport, 1-12 szénatomos alkiltiocsoport, heterociklusoscsoport, arilcsoport, hidroxilcsoport, karbamoilcsoport,karboxilcsoport, 2-12 szénatomos alkoxikarbonilcsoport, cianocsoport,aminocsoport, 1-12 szénatomos alkilaminocsoport, 1-12 szénatomosdialkilaminocsoport vagy -N3 képletű csoport, R4 jelentésehidrogénatom, adott esetben szubsztituált 1-12 szénatomosalkilcsoport, adott esetben szubsztituált 1-12 szénatomosalkoxicsoport, aminocsoport, 1-12 szénatomos alkilaminocsoport, 1-12szénatomos dialkilaminocsoport, 1-12 szénatomos alkiltiocsoport,halogénatom, cianocsoport, karboxilcsoport, 2-12 szénatomosalkoxikarbonilcsoport, heterociklusos csoport,
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21558500P | 2000-06-30 | 2000-06-30 | |
PCT/US2001/020672 WO2002002563A2 (en) | 2000-06-30 | 2001-06-28 | Substituted-triazolopyrimidines as anticancer agents |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0300798A2 true HUP0300798A2 (hu) | 2003-07-28 |
HUP0300798A3 HUP0300798A3 (en) | 2006-02-28 |
Family
ID=22803554
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0300798A HUP0300798A3 (en) | 2000-06-30 | 2001-06-28 | Substituted-triazolopyrimidines and their use as anticancer agents and pharmaceutical compositions containing them |
Country Status (24)
Country | Link |
---|---|
US (1) | US7329663B2 (hu) |
EP (1) | EP1307200A2 (hu) |
JP (1) | JP2004502691A (hu) |
KR (1) | KR20030013475A (hu) |
CN (1) | CN1592624A (hu) |
AR (1) | AR034553A1 (hu) |
AU (2) | AU7306201A (hu) |
BG (1) | BG107277A (hu) |
BR (1) | BR0112038A (hu) |
CA (1) | CA2413802A1 (hu) |
CZ (1) | CZ20024150A3 (hu) |
EA (1) | EA006483B1 (hu) |
GE (1) | GEP20053688B (hu) |
HK (1) | HK1052646A1 (hu) |
HU (1) | HUP0300798A3 (hu) |
IL (1) | IL152869A0 (hu) |
IN (1) | IN2003KO00001A (hu) |
MX (1) | MXPA02011913A (hu) |
NO (1) | NO20026195L (hu) |
NZ (1) | NZ523807A (hu) |
PL (1) | PL360027A1 (hu) |
SK (1) | SK18412002A3 (hu) |
WO (1) | WO2002002563A2 (hu) |
ZA (1) | ZA200300793B (hu) |
Families Citing this family (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6255309B1 (en) | 1999-03-19 | 2001-07-03 | American Cyanomid Co. | Fungicidal trifluoromethylalkylamino-triazolopyrimidines |
WO2002038565A2 (de) * | 2000-11-13 | 2002-05-16 | Basf Aktiengesellschaft | 7-(r)-amino-triazolopyrimidine, deren herstellung und verwendung zur bekämpfung von pflanzenpathogenen pilzen |
AU2002257757B2 (en) * | 2001-04-11 | 2008-05-08 | Basf Aktiengesellschaft | 5-Halogen-6-phenyl-7-fluoralkylamino-triazolopyrimidines as fungicides |
DE60201089T2 (de) * | 2001-04-11 | 2004-12-30 | Basf Ag | 6-(2-chlor-6-fluor-phenyl)-triazolpyrimidine |
DE10121101A1 (de) * | 2001-04-27 | 2002-10-31 | Bayer Ag | Triazolopyrimidine |
DE10121162A1 (de) * | 2001-04-30 | 2002-10-31 | Bayer Ag | Triazolopyrimidine |
DE10124208A1 (de) † | 2001-05-18 | 2002-11-21 | Bayer Ag | Verwendung von Triazolopyrimidin-Derivaten als Mikrobizide |
PL367621A1 (en) * | 2001-07-18 | 2005-03-07 | Basf Aktiengesellschaft | Substituted 6-(2-tolyl)-triazolopyrimidines as fungicides |
NZ535909A (en) | 2002-03-21 | 2007-02-23 | Basf Ag | Fungicidal triazolopyrimidines, methods for producing the same, use thereof for combating harmful fungi and agents containing said substances |
JPWO2004011467A1 (ja) * | 2002-07-29 | 2005-12-15 | 北興化学工業株式会社 | トリアゾロピリミジン誘導体および農園芸用殺菌剤 |
UA80304C2 (en) * | 2002-11-07 | 2007-09-10 | Basf Ag | Substituted 6-(2-halogenphenyl)triazolopyrimidines |
EA200501388A1 (ru) * | 2003-03-31 | 2006-02-24 | Басф Акциенгезельшафт | 7-алкениламинотриазолопиримидины, способ их получения и их применение для борьбы с фитопатогенными грибами, а также содержащие их средства |
DE10325133A1 (de) * | 2003-06-04 | 2004-12-23 | Bayer Cropscience Ag | Triazolopyrimidine |
US20070275961A1 (en) * | 2003-06-04 | 2007-11-29 | Vernalis (Cambridge) Limited. | Triazolo ' 1, 5-A ! Pyrimidines and Their Use in Medicine |
DE10328173A1 (de) * | 2003-06-24 | 2005-01-13 | Bayer Cropscience Ag | Triazolopyrimidine |
DE10328171A1 (de) * | 2003-06-24 | 2005-01-13 | Bayer Cropscience Ag | Triazolopyrimidine |
DE10328481A1 (de) * | 2003-06-25 | 2005-01-13 | Bayer Ag | Triazolopyrimidine |
SI1680425T1 (sl) | 2003-09-24 | 2007-04-30 | Wyeth Corp | 6-((substituirani)fenil)triazolopirimidini kot sredstva proti raku |
US7419982B2 (en) | 2003-09-24 | 2008-09-02 | Wyeth Holdings Corporation | Crystalline forms of 5-chloro-6-{2,6-difluoro-4-[3-(methylamino)propoxy]phenyl}-N-[(1S)-2,2,2-trifluoro-1-methylethyl][1,2,4]triazolo[1,5-a]pyrimidin-7-amine salts |
AU2004275728A1 (en) * | 2003-09-24 | 2005-04-07 | Wyeth Holdings Corporation | 6-aryl-7-halo-imidazo[1,2-a]pyrimidines as anticancer agent |
JPWO2005037837A1 (ja) * | 2003-10-17 | 2006-12-28 | 日本化薬株式会社 | 置換2−アミノ−[1,2,4]トリアゾロ[1,5−a]ピリミジン誘導体及びその用途 |
JP4606015B2 (ja) * | 2003-11-25 | 2011-01-05 | 日本化薬株式会社 | [1,2,4]トリアゾロ[1,5−a]ピリミジン誘導体の新規医薬用途 |
MY179926A (en) | 2003-12-08 | 2020-11-19 | Wyeth Corp | Process for the preparation of tubulin inhibitors |
US20070135453A1 (en) * | 2003-12-17 | 2007-06-14 | Basf Aktiengesellschaft | 6-(2,4,6-Trihalophenyl)triazolopyrimidines, their preparation and their use for controlling harmful fungi, and compositions comprising these compounds |
US20070149588A1 (en) * | 2003-12-17 | 2007-06-28 | Tormo I Blasco Jordi | 6-(2,3,6-Trifluorophenyl)triazolopyrimidines, their preparation and their use for controlling harmful fungi, and compositions comprising these compounds |
WO2005095404A2 (de) * | 2004-03-30 | 2005-10-13 | Basf Aktiengesellschaft | 6-(2-fluorphenyl)-triazolopyrimidine, verfahren zu ihrer herstellung und ihre verwendung zur bekämpfung von schadpilzen sowie sie enthaltende mittel |
BRPI0510804A (pt) * | 2004-05-17 | 2007-11-06 | Basf Ag | compostos, uso de um composto, agente adequado para combater fungos nocivos, e, processo para combater fungos fitopatogênicos |
EP1758457A1 (de) * | 2004-06-09 | 2007-03-07 | Basf Aktiengesellschaft | Triazolopyrimidin-verbindungen und ihre verwendung zur bekämpfung von schadpilzen |
US20070185099A1 (en) * | 2004-06-25 | 2007-08-09 | Carsten Blettner | Triazolopyrimidine compounds and their use for controlling pathogenic fungi |
US20070155738A1 (en) | 2005-05-20 | 2007-07-05 | Alantos Pharmaceuticals, Inc. | Heterobicyclic metalloprotease inhibitors |
WO2006128184A2 (en) * | 2005-05-20 | 2006-11-30 | Alantos-Pharmaceuticals, Inc. | Pyrimidine or triazine fused bicyclic metalloprotease inhibitors |
WO2007011759A2 (en) * | 2005-07-15 | 2007-01-25 | Kalypsys, Inc. | Inhibitors of mitotic kinesin |
WO2007075465A1 (en) * | 2005-12-16 | 2007-07-05 | Wyeth | Dimers and adducts of 6-[(substituted) phenyl] triazolopyrimidines useful as anticancer agents |
WO2007099092A1 (de) * | 2006-02-28 | 2007-09-07 | Basf Se | Substituierte 6-phenyl-7-amino-[1,2,4]-triazolo[1,5-a]pyrimidine und deren verwendung zur bekämpfung von schadpilzen |
WO2007116011A2 (de) * | 2006-04-10 | 2007-10-18 | Basf Se | Substituierte triazolopyrimidine, verfahren zu ihrer herstellung und ihre verwendung zur bekämpfung von schadpilzen sowie sie enthaltende mittel |
JP5231829B2 (ja) | 2007-02-15 | 2013-07-10 | 石原産業株式会社 | ピリジル−トリアゾロピリミジン誘導体又はその塩、それらを含有する有害生物防除剤並びにそれらの製造方法 |
NZ583267A (en) | 2007-08-14 | 2012-03-30 | Bayer Schering Pharma Ag | Fused bicyclic pyrimidines |
CN103889428A (zh) | 2010-10-04 | 2014-06-25 | 肝炎与病毒研究所 | 乙型肝炎病毒抗原分泌的新型抑制剂 |
BR112014030147B1 (pt) | 2012-06-22 | 2019-10-15 | Sumitomo Chemical Company, Limited | Compostos heterocíclicos fundidos, composição e método para controlar pestes |
CN103360398B (zh) * | 2013-07-22 | 2015-03-25 | 山东大学 | 一种三唑并嘧啶类hiv-1逆转录酶抑制剂及其制备方法与应用 |
GB201504565D0 (en) | 2015-03-18 | 2015-05-06 | Takeda Pharmaceutical | Novel compounds |
KR101995533B1 (ko) * | 2017-03-21 | 2019-07-02 | 한국화학연구원 | [1,2,4]트리아졸로[4,3-a]퀴노잘린 아미노 페닐 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 포함하는 BET 단백질 관련 질환의 예방 또는 치료용 약학적 조성물 |
US11390626B2 (en) | 2019-01-29 | 2022-07-19 | Tosk, Inc. | Pyrazolopyrimidine modulators of RAS GTPase |
EP4136089A1 (en) * | 2020-04-14 | 2023-02-22 | The Trustees of The University of Pennsylvania | Substituted {1,2,4,} triazolo{1,5-a} pyrimidine compounds and use in stabilizing microtubules |
US20240043427A1 (en) * | 2020-05-01 | 2024-02-08 | Gilead Sciences, Inc. | Cd73 compounds |
WO2022011171A1 (en) * | 2020-07-08 | 2022-01-13 | Klotho Therapeutics, Inc. | Novel compounds and methods for increasing klotho gene expression |
US11919869B2 (en) | 2021-10-29 | 2024-03-05 | Gilead Sciences, Inc. | CD73 compounds |
WO2023143194A1 (zh) * | 2022-01-25 | 2023-08-03 | 瑞石生物医药有限公司 | 一种ccr4小分子拮抗剂及其用途 |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE55956C (de) | CH. GROOMBRIDGE und W. A. SOUTH in London, 40 New Bond Street | Bremskurbel für Pferdebahn- und andere Wagen | ||
DD55956A (hu) * | ||||
DD61269A (hu) * | ||||
DE61269C (de) | 1891-04-01 | 1892-03-23 | J. NEWBURG in Berlin O., Am Schlesischen Bahnhof Nr. 5 | Waschmaschine |
JPS5827773B2 (ja) * | 1980-02-08 | 1983-06-11 | 持田製薬株式会社 | 癌転移抑制剤 |
US4444774A (en) * | 1982-07-29 | 1984-04-24 | American Cyanamid Company | 7-Heteroaryl[1,2,4]triazolo[1,5-a]pyrimidines |
GB8719368D0 (en) * | 1987-08-15 | 1987-09-23 | Wellcome Found | Heterocyclic compounds |
JPH02212488A (ja) * | 1989-02-13 | 1990-08-23 | Shinichiro Shimizu | トリアゾールピリミジン誘導体 |
US5593996A (en) * | 1991-12-30 | 1997-01-14 | American Cyanamid Company | Triazolopyrimidine derivatives |
US5387747A (en) * | 1992-02-24 | 1995-02-07 | Laboratoires Upsa | Triazolopyrimidine derivatives which are angiotensin II receptor antagonists, their methods of preparation and pharmaceutical compositions in which they are present |
IL108747A (en) * | 1993-03-04 | 1999-03-12 | Shell Int Research | Mushroom-killing preparations containing a history of 6 metamorphoses of 5 - 7 Dihalo - 1, 2 - 4 Triazlo [A-1,5] Pyrimidine Certain such new compounds and their preparation |
GB9321162D0 (en) * | 1993-10-13 | 1993-12-01 | Boots Co Plc | Therapeutic agents |
US5869486A (en) * | 1995-02-24 | 1999-02-09 | Ono Pharmaceutical Co., Ltd. | Fused pyrimidines and pyriazines as pharmaceutical compounds |
US5948783A (en) * | 1997-04-14 | 1999-09-07 | American Cyanamid Company | Fungicidal trifluoromethylalkylamino-triazolopyrimidines |
US6117876A (en) * | 1997-04-14 | 2000-09-12 | American Cyanamid Company | Fungicidal trifluorophenyl-triazolopyrimidines |
US6255309B1 (en) * | 1999-03-19 | 2001-07-03 | American Cyanomid Co. | Fungicidal trifluoromethylalkylamino-triazolopyrimidines |
US5994360A (en) * | 1997-07-14 | 1999-11-30 | American Cyanamid Company | Fungicidal 5-alkyl-triazolopyrimidines |
US6020338A (en) * | 1998-02-11 | 2000-02-01 | American Cyanamid Company | Fungicidal 7-alkyl-triazolopyrimidines |
US6380202B1 (en) * | 1998-09-25 | 2002-04-30 | Basf Aktiengesellschaft | Fungicidal fluoro-substituted 7-heterocyclyl-triazolopyrimidines |
US6165940A (en) * | 1998-09-25 | 2000-12-26 | American Cyanamid Co. | Non-aqueous suspension concentrate |
FR2784380B1 (fr) * | 1998-09-25 | 2002-09-06 | American Cyanamid Co | Triazolopyrimidines 7-oxy- et 7-thio-substituees fongicides |
MY125533A (en) * | 1999-12-06 | 2006-08-30 | Bristol Myers Squibb Co | Heterocyclic dihydropyrimidine compounds |
JP2001322933A (ja) * | 2000-05-15 | 2001-11-20 | Ucb Sa | Cd40シグナル遮断剤 |
DE10121101A1 (de) * | 2001-04-27 | 2002-10-31 | Bayer Ag | Triazolopyrimidine |
DE10121102A1 (de) * | 2001-04-27 | 2002-11-07 | Bayer Ag | Triazolopyrimidine |
DE10121162A1 (de) * | 2001-04-30 | 2002-10-31 | Bayer Ag | Triazolopyrimidine |
US7037902B2 (en) * | 2002-07-03 | 2006-05-02 | Receptron, Inc. | Affinity small molecules for the EPO receptor |
US7419982B2 (en) * | 2003-09-24 | 2008-09-02 | Wyeth Holdings Corporation | Crystalline forms of 5-chloro-6-{2,6-difluoro-4-[3-(methylamino)propoxy]phenyl}-N-[(1S)-2,2,2-trifluoro-1-methylethyl][1,2,4]triazolo[1,5-a]pyrimidin-7-amine salts |
SI1680425T1 (sl) * | 2003-09-24 | 2007-04-30 | Wyeth Corp | 6-((substituirani)fenil)triazolopirimidini kot sredstva proti raku |
-
2001
- 2001-06-28 NZ NZ523807A patent/NZ523807A/en unknown
- 2001-06-28 AU AU7306201A patent/AU7306201A/xx active Pending
- 2001-06-28 HU HU0300798A patent/HUP0300798A3/hu unknown
- 2001-06-28 CZ CZ20024150A patent/CZ20024150A3/cs unknown
- 2001-06-28 BR BR0112038-7A patent/BR0112038A/pt not_active IP Right Cessation
- 2001-06-28 MX MXPA02011913A patent/MXPA02011913A/es not_active Application Discontinuation
- 2001-06-28 CA CA002413802A patent/CA2413802A1/en not_active Abandoned
- 2001-06-28 EP EP01952295A patent/EP1307200A2/en not_active Withdrawn
- 2001-06-28 GE GE5104A patent/GEP20053688B/en unknown
- 2001-06-28 PL PL36002701A patent/PL360027A1/xx not_active Application Discontinuation
- 2001-06-28 SK SK1841-2002A patent/SK18412002A3/sk not_active Application Discontinuation
- 2001-06-28 JP JP2002507815A patent/JP2004502691A/ja active Pending
- 2001-06-28 CN CNA018120555A patent/CN1592624A/zh active Pending
- 2001-06-28 AU AU2001273062A patent/AU2001273062B2/en not_active Ceased
- 2001-06-28 WO PCT/US2001/020672 patent/WO2002002563A2/en not_active Application Discontinuation
- 2001-06-28 IL IL15286901A patent/IL152869A0/xx unknown
- 2001-06-28 KR KR1020027017998A patent/KR20030013475A/ko not_active Application Discontinuation
- 2001-06-28 EA EA200300091A patent/EA006483B1/ru not_active IP Right Cessation
- 2001-06-29 AR ARP010103116A patent/AR034553A1/es not_active Application Discontinuation
- 2001-06-29 US US09/895,975 patent/US7329663B2/en not_active Expired - Fee Related
-
2002
- 2002-11-15 BG BG107277A patent/BG107277A/bg unknown
- 2002-12-23 NO NO20026195A patent/NO20026195L/no not_active Application Discontinuation
-
2003
- 2003-01-01 IN IN1KO2003 patent/IN2003KO00001A/en unknown
- 2003-01-29 ZA ZA200300793A patent/ZA200300793B/xx unknown
- 2003-07-07 HK HK03104812.5A patent/HK1052646A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
NO20026195D0 (no) | 2002-12-23 |
WO2002002563A2 (en) | 2002-01-10 |
MXPA02011913A (es) | 2003-04-22 |
HUP0300798A3 (en) | 2006-02-28 |
US20020068744A1 (en) | 2002-06-06 |
EP1307200A2 (en) | 2003-05-07 |
BR0112038A (pt) | 2003-04-01 |
BG107277A (bg) | 2004-01-30 |
AR034553A1 (es) | 2004-03-03 |
CZ20024150A3 (cs) | 2003-09-17 |
IL152869A0 (en) | 2003-06-24 |
AU2001273062B2 (en) | 2005-11-24 |
IN2003KO00001A (hu) | 2005-12-02 |
EA006483B1 (ru) | 2005-12-29 |
WO2002002563A3 (en) | 2003-01-03 |
ZA200300793B (en) | 2004-07-20 |
NO20026195L (no) | 2003-02-27 |
US7329663B2 (en) | 2008-02-12 |
CA2413802A1 (en) | 2002-01-10 |
CN1592624A (zh) | 2005-03-09 |
NZ523807A (en) | 2004-09-24 |
EA200300091A1 (ru) | 2003-08-28 |
SK18412002A3 (sk) | 2003-06-03 |
AU7306201A (en) | 2002-01-14 |
GEP20053688B (en) | 2005-12-12 |
KR20030013475A (ko) | 2003-02-14 |
HK1052646A1 (zh) | 2003-09-26 |
PL360027A1 (en) | 2004-09-06 |
JP2004502691A (ja) | 2004-01-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0300798A2 (hu) | Szubsztituált triazolopirimidin-származékok és alkalmazásuk rákellenes hatóanyagként és ezeket tartalmazó gyógyszerkészítmények | |
EA200701780A1 (ru) | Противоопухолевое средство | |
HUP0105414A2 (hu) | Pirrolo-izokinolin-, azepino- és diazepino-indol-származékok, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények | |
CA2617817A1 (en) | Thiazole derivatives for treating or preventing sleep disorders | |
ATE361287T1 (de) | Neue indol-2-on derivate | |
BR0014137A (pt) | Composto, método para inibir a aurora 2 quinase em um animal de sangue quente, uso de um composto, e, composição farmacêutica | |
EP1259487B8 (en) | 2-amino-nicotinamide derivatives and their use as vegf-receptor tyrosine kinase inhibitors | |
NO20055655D0 (no) | Anvendelse av azetidinkarboksamidderivater i terapi | |
ATE370138T1 (de) | Neue imidazopyridine und ihre verwendung | |
ATE537830T1 (de) | Nicotinamid derivate und ihre verwendung als therapeutika | |
TNSN05080A1 (en) | NOVEL ANTIMYCOBACTERIAL COMPOUNDS (as filed) AND PYRROLE DERIVATIVES AS ANTIMYCOBACTERIAL COMPOUNDS (as published) | |
ATE232520T1 (de) | Imidazolidin-4-on derivate verwendbar als antikrebsmittel | |
DE60206911D1 (de) | Imidazol-2-carbonsäureamid derivate als raf-kinase-inhibitoren | |
AR050045A1 (es) | Derivados de pirrolo[3,4-c]pirazol activos como inhibidores de quinasa, procedimiento para su preparacion y composiciones farmaceuticas que los comprenden | |
ATE279192T1 (de) | Die verwendung eines benzimidazoles zur herstellung eines medikamentes zur krebsvorbeugung | |
BRPI0515991A (pt) | derivados de bisariluréia substituìda heterocìclica como inibidores de cinase | |
ATE287397T1 (de) | Chinoline derivate und ihre anwendung als antitumor agentien | |
TW200621227A (en) | Medicament for preventing or treating fatty liver | |
AU2011271480A1 (en) | Riminophenazines with 2-(heteroaryl)amino substituents and their anti-microbial activity | |
CA2472008C (en) | Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitors | |
CY1113801T1 (el) | Παραγωγο κιναζολινης και φαρμακευτικο ειδος | |
KR900014339A (ko) | 헤테로시클릭 화합물, 그의 제조방법, 이를 함유하는 제약 조성물 및 의약으로서의 용도 | |
TW200635898A (en) | Benzoyl-tetrahydropyridine | |
EA200200379A2 (ru) | Новые соединения пиримидин-4-она, способ их получения и содержащие их фармацевтические композиции | |
SE9700803L (sv) | Farmaceutisk komposition för behandling av s k restless legs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD9A | Lapse of provisional protection due to non-payment of fees |